Sean Werner - Mar 18, 2025 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Technology Officer
Signature
/s/ Sean Werner
Stock symbol
BLFS
Transactions as of
Mar 18, 2025
Transactions value $
$0
Form type
4
Date filed
3/20/2025, 07:07 PM
Previous filing
Mar 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Award +22.9K +471.1% 27.8K Mar 18, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2025 compensation.